1 |
Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease[J]. Lancet, 2006, 368(9531): 230-239.
|
2 |
Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer[J]. Gut Liver, 2012, 6(2): 172-187.
|
3 |
Paumgartner G, Sauerbruch T. Gallstones: pathogenesis[J]. Lancet, 1991, 338(8775): 1117-1121.
|
4 |
Zhang XY, Cui GB, Ma KJ, et al. Sphincter of Oddi dysfunction in hypercholesterolemic rabbits[J]. Eur J Gastroenterol Hepatol, 2008, 20(3): 202-208.
|
5 |
Chapman WC, Peterkin GA 3rd, LaMorte WW, et al. Alterations in biliary motility correlate with increased gallbladder prostaglandin synthesis in early cholelithiasis in prairie dog[J]. Dig Dis Sci, 1989, 34(9): 1420-1424.
|
6 |
Behar J, Corazziari E, Guelrud M, et al. Functional gallbladder and sphincter of oddi disorders[J]. Gastroenterology, 2006, 130(5): 1498-1509.
|
7 |
Linder JD, Geels W, Wilcox CM. Prevalence of sphincter of Oddi dysfunction: can results from specialized centers be generalized?[J]. Dig Dis Sci, 2002, 47(11): 2411-2415.
|
8 |
Baillie J, Kimberly J. Prospective comparison of secretin-stimulated MRCP with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III [J]. Gut, 2007, 56(6): 742-744.
|
9 |
吴硕东, 于宏, 王昊霖, 等. Oddi括约肌与胆管色素结石形成关系的探讨[J]. 中华外科杂志, 2007, 57(1): 58-61.
|
10 |
Lu W, Tang D, Cao S. The expression of calponin in Oddi’s sphincters and its actions during gallstone formation[J]. Zhonghua Yi Xue Za Zhi, 1997, 77(11): 812-814.
|
11 |
Szilvassy Z, Nagy I, Szilvássy Z, et al. Beneficial effect of lovastation on sphincter of Oddi dyskinesia in hypercholesterolemia and hypertriglyceridemia[J]. Am J Gastroenterol, 1997, 92(5): 900-902.
|
12 |
Woods CM, Saccone GT. Neurohormonal regulation of the sphincter of Oddi[J]. Curr Gastroenterol Rep, 2007, 9(2): 165-170.
|
13 |
何彦安, 雷正明, 叶明新, 等. 胆囊黏膜G蛋白偶联胆汁酸受体1表达与胆囊结石致石胆汁关系的研究[J]. 中华肝胆外科杂志, 2012, 18(4): 256-260.
|
14 |
Zhang ZH, Wu SD, Wang B, et al. Sphincter of Oddi hypomotility and its relationship with duodenal-biliary reflux, plasma motilin and serum gastrin[J]. World J Gastroenterol, 2008, 14(25): 4077-4081.
|
15 |
Zhang ZH, Wu SD, Su Y, et al. Differences and significance of motilin, vasoactive intestinal peptide and gastrin in blood and gallbladder tissues of patients with gallstones[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(1): 58-64.
|